Quick Takeaways
- Pontifax Management 4 G.P. (2015) Ltd. filed SCHEDULE 13G for Climb Bio, Inc. Common Stock, par value $0.0001 per share (CLYM).
- Disclosed ownership: 7.7%.
- Date of event: 27 Jun 2024.
Pontifax Management 4 G.P. (2015) Ltd. - 27 Jun 2024 SCHEDULE 13G Report for Climb Bio, Inc. Common Stock, par value $0.0001 per share (CLYM)
- Filing Manager
- Pontifax Management 4 G.P. (2015) Ltd.
- Reporting Manager
- Pontifax VI G.P. L.P.
- Symbol
- CLYM
- Shares outstanding
- 67,615,325 shares
- Disclosed Ownership
- 5,206,380 shares
- Ownership
- 7.7%
- Form type
- SCHEDULE 13G
- Filing time
- 18 Sep 2025, 09:26:05 UTC
- Date of event
- 27 Jun 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Pontifax Management 4 G.P. (2015) Ltd. disclosed 7.7% ownership in Climb Bio, Inc. Common Stock, par value $0.0001 per share (CLYM) on 27 Jun 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 18 Sep 2025, 09:26.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Pontifax VI G.P. L.P. | 7.7% | 5,206,380 | 0 | 5,206,380 | /s/ Pontifax Management 4 G.P. (2015) Ltd. | Pontifax Management 4 G.P. (2015) Ltd./General Partner | |
| Pontifax Management 4 G.P. (2015) Ltd. | 7.7% | 5,206,380 | 0 | 5,206,380 | /s/ Ran Nussbaum | Ran Nussbaum/Director | |
| Ran Nussbaum | 7.7% | 5,206,380 | 0 | 5,206,380 | /s/ Ran Nussbaum | Ran Nussbaum/Director | |
| Tomer Kariv | 7.7% | 5,206,380 | 0 | 5,206,380 | /s/ Tomer Kariv | TOMER KARIV |